GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » International Isotopes Inc (OTCPK:INIS) » Definitions » Degree of Operating Leverage

INIS (International Isotopes) Degree of Operating Leverage : -9.54 (As of Mar. 2025)


View and export this data going back to 1997. Start your Free Trial

What is International Isotopes Degree of Operating Leverage?

Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. International Isotopes's Degree of Operating Leverage for the quarter that ended in Mar. 2025 was -9.54. The higher Degree of Operating Leverage, the higher operating risk the company will take.

The industry rank for International Isotopes's Degree of Operating Leverage or its related term are showing as below:

INIS's Degree of Operating Leverage is ranked better than
86% of 950 companies
in the Drug Manufacturers industry
Industry Median: 0.64 vs INIS: -9.54

International Isotopes Degree of Operating Leverage Historical Data

The historical data trend for International Isotopes's Degree of Operating Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Isotopes Degree of Operating Leverage Chart

International Isotopes Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Degree of Operating Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only -128.60 -31.40 1,939.39 -16.31 -12.24

International Isotopes Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Degree of Operating Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.97 1,098.47 -13.52 -12.24 -9.54

Competitive Comparison of International Isotopes's Degree of Operating Leverage

For the Drug Manufacturers - Specialty & Generic subindustry, International Isotopes's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Isotopes's Degree of Operating Leverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, International Isotopes's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where International Isotopes's Degree of Operating Leverage falls into.


;
;

International Isotopes Degree of Operating Leverage Calculation

International Isotopes's Degree of Operating Leverage for the quarter that ended in Mar. 2025 is calculated as:

Degree of Operating Leverage=% Change in EBIT**/% Change in Revenue
=( 0.381 (Mar. 2025) / -0.545 (Mar. 2024) - 1 )/( 14.234 (Mar. 2025) / 12.082 (Mar. 2024) - 1 )
=-1.6991/0.1781
=-9.54***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


International Isotopes  (OTCPK:INIS) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.


International Isotopes Degree of Operating Leverage Related Terms

Thank you for viewing the detailed overview of International Isotopes's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


International Isotopes Business Description

Traded in Other Exchanges
N/A
Address
4137 Commerce Circle, Idaho Falls, ID, USA, 83401
International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources. International Isotopes also distributes a varied selection of radioisotopes and radiochemicals for medical and clinical research, and pharmacy compounding. International Isotopes's business consists of four business segments: Nuclear Medicine Standards, Cobalt Products, The Theranostics Products Segment, The Medical Devices segment and Fluorine Products. Geographically, it generates the majority of its revenue from Theranostics Products.
Executives
Shahe Bagerdjian officer: President 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
W Matthew Cox officer: Chief Financial Officer C/O INTERNATIONAL ISOTOPES INC., 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Christopher G Grosso director, 10 percent owner C/O KERSHNER GROSSO & CO, 480 BROADWAY, SARASOTA SPRINGS NY 12866
Robert Atcher director 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Laurie Mckenzie-carter officer: Chief Financial Officer 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Steve Laflin director, officer: Pres. & CEO 1258 E AIRPORT ROAD, BLACKFOOT ID 83221
William W Nicholson 10 percent owner 121 NORTH POST OAK LANE STE 2105, HOUSTON TX 77024
Ralph M Richard director, 10 percent owner 350 SHORE DRIVE, OAKDALE NY 11769
John M Mccormack 10 percent owner 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Walter D Ohearn other: Part of 13D group 1115 5TH AVENUE, NEW YORK NY 10128
Keane Marie C & Keane James Jtwros 10 percent owner